Explore more publications!
Africa Daily Journal
Got News to Share?

Africa Daily Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa Daily Journal.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on April 9, 2026

Rhythm Pharmaceuticals to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026
Apr. 9, 2026

Rhythm Pharmaceuticals to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026

Indeterminate GlobeNewswire
Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%
Apr. 9, 2026

Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%

Indeterminate GlobeNewswire
Cerevance to Present Positive Phase 2 Solengepras Data in Parkinson’s Disease at the American Academy of Neurology 2026 Annual Meeting
Apr. 9, 2026

Cerevance to Present Positive Phase 2 Solengepras Data in Parkinson’s Disease at the American Academy of Neurology 2026 Annual Meeting

Indeterminate GlobeNewswire
Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026
Apr. 9, 2026

Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026

Indeterminate GlobeNewswire
Kyverna Therapeutics to Host Conference Call on New Data Across Neuroimmunology Franchise at AAN 2026
Apr. 9, 2026

Kyverna Therapeutics to Host Conference Call on New Data Across Neuroimmunology Franchise at AAN 2026

Indeterminate GlobeNewswire
AIM ImmunoTech to Participate in Live Virtual Investor Closing Bell Event
Apr. 9, 2026

AIM ImmunoTech to Participate in Live Virtual Investor Closing Bell Event

Indeterminate GlobeNewswire
SONORO GOLD ANNOUNCES FURTHER EXPANSION OF CERRO CALICHE GOLD PROPERTY
Apr. 9, 2026

SONORO GOLD ANNOUNCES FURTHER EXPANSION OF CERRO CALICHE GOLD PROPERTY

Indeterminate GlobeNewswire
La fusion entre PDI et Robex entre dans sa phase de mise en œuvre
Apr. 9, 2026

La fusion entre PDI et Robex entre dans sa phase de mise en œuvre

Indeterminate GlobeNewswire
Fusion von PDI und Robex auf dem Weg zur Umsetzung
Apr. 9, 2026

Fusion von PDI und Robex auf dem Weg zur Umsetzung

Indeterminate GlobeNewswire
NevGold Intercepts 1.11% Antimony Over 6.1 Meters, Within 1.93 g/t AuEq Over 100.6 Meters (1.07 g/t Au And 0.22% Antimony) From Surface; Focus On Maiden Antimony-Gold Mineral Resource Estimate and Near-Term Antimony Production
Apr. 9, 2026

NevGold Intercepts 1.11% Antimony Over 6.1 Meters, Within 1.93 g/t AuEq Over 100.6 Meters (1.07 g/t Au And 0.22% Antimony) From Surface; Focus On Maiden Antimony-Gold Mineral Resource Estimate and Near-Term Antimony Production

Indeterminate GlobeNewswire
Entrée Resources Provides JV Licenses Update and Drill and Regional Exploration Results
Apr. 9, 2026

Entrée Resources Provides JV Licenses Update and Drill and Regional Exploration Results

Indeterminate GlobeNewswire
Dynacor Group Announces CEO Transition
Apr. 9, 2026

Dynacor Group Announces CEO Transition

Indeterminate GlobeNewswire
Groupe Dynacor annonce une transition au poste de chef de la direction
Apr. 9, 2026

Groupe Dynacor annonce une transition au poste de chef de la direction

Indeterminate GlobeNewswire
Big Bear Gold Corp. Announces AGM Results and Adoption of Omnibus Long-Term Incentive Plan
Apr. 9, 2026

Big Bear Gold Corp. Announces AGM Results and Adoption of Omnibus Long-Term Incentive Plan

Indeterminate GlobeNewswire
NIOB Authorized to Drill at Two More Québec Projects
Apr. 9, 2026

NIOB Authorized to Drill at Two More Québec Projects

Indeterminate GlobeNewswire
InflaRx Reports New Mechanistic Data for Izicopan Supporting its Potential as a Best-in-Class C5aR Inhibitor
Apr. 9, 2026

InflaRx Reports New Mechanistic Data for Izicopan Supporting its Potential as a Best-in-Class C5aR Inhibitor

Indeterminate GlobeNewswire
Invivyd Announces REVOLUTION Program Progress and Advancement of Novel, Potential First- and Best-in-Class Measles Monoclonal Antibody Candidate VMS063 for Treatment and Prevention of Measles
Apr. 9, 2026

Invivyd Announces REVOLUTION Program Progress and Advancement of Novel, Potential First- and Best-in-Class Measles Monoclonal Antibody Candidate VMS063 for Treatment and Prevention of Measles

Indeterminate GlobeNewswire
Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th  
Apr. 9, 2026

Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th  

Indeterminate GlobeNewswire
Rani Therapeutics Appoints Dr. Sara Kenkare-Mitra as Strategic Advisor to Advance Platform and Clinical Strategy
Apr. 9, 2026

Rani Therapeutics Appoints Dr. Sara Kenkare-Mitra as Strategic Advisor to Advance Platform and Clinical Strategy

Indeterminate GlobeNewswire
Foghorn Therapeutics to Present New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting
Apr. 9, 2026

Foghorn Therapeutics to Present New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions